Formulation optimization of topical gel formulation containing micro-emulsion of terbinafine hydrochloride with simplex lattice design

Micro and Nanosystems

Volumn 3, Issue 1, 2011, Pages 1-7

  Dabhi, Mahesh R ^a   Nagori, Stavan A ^b   Sheth, Navin R ^a   Patel, Nilesh K ^a   Dudhrejiya, Ashvin V ^a  

^a SAURASHTRA UNIVERSITY   (India)

^b L M COLLEGE OF PHARMACY   (India)

Author keywords

Drug diffusion; Microemulsion; Terbinafine hydrochloride; Topical drug delivery

Indexed keywords

CARBOPOL; CO-SURFACTANTS; DIFFUSIN; DRUG DIFFUSION; FORMULATION OPTIMIZATION; IN-VITRO; INDEPENDENT VARIABLES; MICROEMULSION SYSTEMS; OIL PHASE; PHYSICOCHEMICAL PROPERTY; POTENTIAL APPLICATIONS; PSEUDOTERNARY PHASE DIAGRAMS; SIMPLEX-LATTICE DESIGN; TERBINAFINE; TOPICAL DRUGS; TWEEN 80;

COTTONSEED OIL; DRUG DELIVERY; EMULSIFICATION; ETHANOL; GELS; OILSEEDS; OPTIMIZATION; PHASE DIAGRAMS; SURFACE ACTIVE AGENTS;

MICROEMULSIONS;

EID: 79953772918     PISSN: 18764029     EISSN: 18764037     Source Type: Journal    
DOI: 10.2174/1876402911103010001     Document Type: Article

References (39)

1. Behl, C; Char, H.S.; Patel, S.B.; Mehta, D.B.; Piemontese, D.; Malick, A.W. In vivo and in vitro skin uptake and permeation studies; critical considerations and factors, which affect them, In: Shah BP, Maibach HI, eds. Topical Drug Bioavailability, Bioequivalence and Penetration. New York, NY: Plenum Press, 1993, 225-259.
2. Marjukka, S.T.; Bouwstra, JA.; Urtti, A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J. Control. Rel, 1999, 59, 149-161.
3. Green, P.G.; Flanagan, M.; Shroot, B.; Guy R.H. Iontophoretic drug delivery. In: K.A. Walters, J. Hadgraft, eds. Pharmaceutical Skin Penetration Enhancement. New York, NY: Marcel Dekker, 1993, pp. 311-333.
4. Gordon, R.D.; Peterson, T.A. Myths about transdermal drug delivery. Drug Deliv. Technol, 2003,5, 1-4.
5. Antifungal gel formulations, United States Patent 5110809 http://www.freepatentsonline.com/5110809.html
6. Sweetman, C.S. Martindale the complete drug reference., 33rd ed. Pharmaceutical Press, 2002, pp. 394.
7. Drug information antifungal antibiotics. AHFS, 2001, 126-8.
8. Tenjarla, S. Microemulsions: an overview and pharmaceutical applications. Crit. Rev. Ther Drug Carrier Syst., 1999, 16, 461-521.
9. Kreilgaard, M. Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev, 2002, 54, 77-98.
10. Lawrence, M.J.; Rees, G.D. Microemulsion-basedmedia as novel drug delivery systems. Adv. Drug Deliv. Rev, 2000, 45, 89-121.
11. Changez, M.; Varshney, M. Aerosol-OT microemulsions as trans-dermal carriers of tetracaine hydrochloride. Drug Dev Ind. Pharm., 2000,26,507-512.
12. Baroli, B.; L'opez-Quintela, M.A.; Delgado-Charro, M.B.; Fadda, A.M.; Blanco-M'endez, J. Microemulsions for topical delivery of 8-methoxsalen. J. Control Rel, 2000, 69, 209-218.
13. Lee, P.J.; Langer, R.; Shastri, V.P. Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm. Res., 2003, 20, 264-269.
14. Gupta, R.R.; Jain, S.K.; Varshney, M. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf. B: Biointerf, 2005, 41, 25-32.
15. Peltola, S.; Saarinen-Savolainen, P.; Kiesvaara, J.; Suhonen, T.M.; Urtti, A. Microemulsions for topical delivery of estradiol. Int. J. Pharm., 2003, 254,99-107.
16. Changez, M.; Chander, J.; Dinda, A.K. Transdermal permeation of tetracaine hydrochloride by lecithin microemulsion: in vivo. Colloids Surf. B: Biointerf, 2006, 48, 58-66.
17. Chen, H.B.; Chang, X.L.; Du, D.R.; Li, J.; Xu, H.B.; Yang X.L. Microemulsion based hydrogel formulation of ibuprofen for topical delivery. Int. J. Pharm., 2006, 315, 52-58.
18. Panigrahi, L.; Goshal, S.K. Effect of permeation enhancers on the release and permeation kinetics of lincomycin hydrochloride gel formulations through mouse skin. Indian. J. Pharm. Sei., 2006, 68(2), 205-211.
19. Attwood, D. Microemulsions. In: Kreuter J, ed. Colloidal Drug Deliv. Sys., New York, NY: Marcel Dekker, 1994, pp. 31-71.
20. Sreenivasa reddy, M.; Mutalik S. Preparation and evaluation of minoxidil gels for topical application in alopecia. Indian J. Pharm. Sei., 2006, 68(4), 432-436.
21. Sankar, V.; Chandrasekaran, A.K.; Durga, S. Formulation and stability evaluation of diclofenac sodium opthalamic gels. Indian J. Pharm. Sei., 2005, 67(4), 473-476.
22. Jumaa, M.; Kleinebudde, P.; M'uller, B.W. Mixture experiments with the oil phase of parenteral emulsions. Eur J. Pharm. Bio-pharm., 1998, 46, 161-167.
23. Subramanian, N.; Ray, S.; Ghosal, S.K.; Bhadra, R.; Moulik, S.P Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol. Pharm. Bull., 2004,27,1993-1999.
24. Li, H.; Pan, W.S.; Li, J.Y Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev. Ind. Pharm., 2004, 30, 657-666.
25. Li, H.; Pan, W.S.; Wu, Z.; Li, J.Y; Xia, L.X. Optimization of microemulsion containing vinpocetine and its physicochemical properties. Yao Xue Xue Bao, 2004, 59,681-685.
26. Hong, W.; Wu, C.Z. Experiment Design and Analysis-principles, Operation and Cases. China Forestry Press, Beijing, 2004.
27. Mao, S.S.; Zhou, J.X.; Chen, Y Design of Experiment. China Statistics Press, Beijing, 2004.
28. Ren, L.Q. Optimum Design and Analysis of Experiments, 2nd ed. High Education Press, Beijing, 2003.
29. Salomon, C.J.; Bravo, S.A.; Lamas, MA. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices. J. Pharm. Pharmaceut. Sei., 2002, 5(3), 213-219.
30. Kreilgaard, M.; Pedersen, E.J.; Jaroszewski, J.W. NMR characterisation and transdermal drug delivery potential of microemulsion systems. J. Control. Rel, 2000, 69, 421-433.
31. Sintov, A.C.; Shapiro, L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J. Control. Rel, 2004, 95, 173-183.
32. Paolino, D.; Ventura, CA.; Nistico, S.; Puglisi, G.; Fresta, M. Lecithin microemulsions for the topical administration of ketopro-fen: percutaneous adsorption throughhumanskin and in vivohuman-skin tolerability. Int. J. Pharm., 2002, 244, 21-31.
33. Kogan, A.; Garti, N. Microemulsions as transdermal drug delivery vehicles. Adv. ColloidInterf. Sei., 2006,123-126, 369-385.
34. Zhao, X.; Liu, J.P.; Zhang, X.; Li Y Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int. J. Pharm.,2006, 327, 58-64.
35. Biruss, B.; Kahlig, H.; Valenta, C. Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones. Int. J. Pharm., 2007, 328, 142-151.
36. Yuan, Y; Li, S.M; Mo, F.K.; Zhang, D.F. Investigation of microemulsion system for transdermal delivery of meloxicam. Int. J. Pharm., 2006, 327,117-123.
37. Ghosh, P.K.; Umrethia, M.; Majithiya, R.J.; Murthy, R.S.R. Preparation and physicochemical characterisation of caprylocapryl mac-rogol -8- glycerides microemulsion for oral drug delivery. Ars. Pharm., 2004, 45, 353-372.
38. Mohammed, C; Manoj, V. Aerosol-OT microemulsions as trans-dermal carriers of tatracaine hydrochloride. Drug Dev. Ind. Pharm., 2000,26,507-512.
39. st edn. Cambridge: Marcel Dekker, 2005.